EU Increases Chia Maximum for Food Products
Now, European formulators can make products with twice as much chia.
The European Commission ruled on January 22, 2013, to increase the allowable inclusion rate for chia seeds (Salvia hispanica) in various food products, and to allow the sale of prepackaged chia seeds throughout Europe.
Chia seeds first gained their EU “novel food ingredient” status in 2009; at the time, they were granted a maximum usage level of 5% of finished products. But, after some petitioning from The Chia Company in Australia, the United Kingdom’s food assessment body approved a request to double the maximum inclusion rate to 10% of finished products, including baked products, breakfast cereals, and fruit, nut, and seed mixes. In January, the EC approved this 10% inclusion rate. The decision also approves the sale of prepackaged chia seeds with a recommended daily intake to not exceed 15 g.
Initial concerns about a lack of toxicology data around chia consumption were abated once The Chia Company provided satisfactory explanation to the Commission and EU Member States.
Chia is a member of the mint (Lamiaceae) family. Its seeds are high in fiber, omega-3 alpha-linolenic acid, protein, and various minerals.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The 2023 Supplement Consumer: Immune Health and Beyond
April 19th 2024Did you know two-out-of-three U.S. supplement consumers say their immune health has become more important to them, yet only 38% would describe their immune health as “very healthy?” There’s an opportunity to meet consumers in their growing desire to live healthier lifestyles and help them redefine resilience. IMMUSETM is the universal postbiotic for year-round immune support. Unlock exclusive consumer insights and discover the formulation opportunities with IMMUSETM with this consumer research.
